Hims & Hers Health (HIMS) awards 8,223 RSUs to board director

Rhea-AI Filing Summary

Schultz Kare reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that director Schultz Kare received a grant of 8,223 Restricted Stock Units (RSUs), each representing a right to receive one share of Class A Common Stock. Subject to continuous service, these RSUs will vest in full on the first quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schultz Kare

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit F1, F2	8,223	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 8,223 shares (Direct)

Footnotes (2)

1. F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.

Key Figures

RSUs granted: 8,223 units Underlying shares: 8,223 shares Price per RSU: $0.00 per unit +1 more

4 metrics

RSUs granted 8,223 units Restricted Stock Units granted to director Schultz Kare on 2026-08-12

Underlying shares 8,223 shares Class A Common Stock underlying the RSU award

Price per RSU $0.00 per unit Stated transaction price for the RSU grant

Holdings after grant 8,223 units Total RSUs held following the reported transaction

Key Terms

Restricted Stock Unit, continuous service, annual stockholder meeting, quarterly vesting date

4 terms

Restricted Stock Unit financial

"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

continuous service financial

"Subject to continuous service, the RSUs will vest in full on the first"

annual stockholder meeting financial

"after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

quarterly vesting date financial

"will vest in full on the first Company quarterly vesting date to occur after"

FAQ

What insider transaction did HIMS report for Schultz Kare on this Form 4?

Hims & Hers Health, Inc. reported that director Schultz Kare received 8,223 RSUs, each representing a right to one share of Class A Common Stock, as a grant or award.

How many shares are covered by Schultz Kare’s RSU grant at HIMS?

The reported grant covers 8,223 Restricted Stock Units, corresponding to 8,223 shares of Class A Common Stock underlying the award, with post-transaction holdings of 8,223 RSUs.

What are the vesting conditions for Schultz Kare’s RSUs at Hims & Hers (HIMS)?

The RSUs vest in full on the first quarterly vesting date after the earlier of the company’s next annual stockholder meeting or the first anniversary of the award’s grant date, subject to continuous service.

Did Schultz Kare buy or sell HIMS shares in the market in this filing?

No market purchase or sale is reported. The Form 4 shows an award of 8,223 RSUs at a stated price of $0.00 per unit, reflecting a compensation-related grant, not an open-market trade.

Is this HIMS Form 4 transaction under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnotes do not state that the RSU grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 04:23 PM Accepted by SEC EDGAR 08/14/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schultz Kare

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/12/2026		A		8,223		(2)	(2)	Class A Common Stock	8,223	$0	8,223	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Kare Schultz	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)